Annual report [Section 13 and 15(d), not S-K Item 405]

Geographic and segmental information (Details)

v3.25.1
Geographic and segmental information (Details)
12 Months Ended
Dec. 31, 2024
segment
Major Customers  
Number of reportable segments 1
Revenue Benchmark [Member] | Customer Concentration Risk | Galapagos, Inc.  
Major Customers  
Concentration risk (as a percentage) 0.00%
Revenue Benchmark [Member] | Customer Concentration Risk | Genentech, Inc.  
Major Customers  
Concentration risk (as a percentage) 93.00%
Revenue Benchmark [Member] | Customer Concentration Risk | GSK Collaboration And License Agreement  
Major Customers  
Concentration risk (as a percentage) 7.00%